BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 224 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $20,007,000 | -4.3% | 137,306 | -22.1% | 1.89% | +27.2% |
| Q1 2022 | $20,902,000 | -33.1% | 176,283 | -22.3% | 1.49% | -24.9% |
| Q4 2021 | $31,265,000 | +11.5% | 226,871 | +12.4% | 1.98% | -3.4% |
| Q3 2021 | $28,047,000 | -20.6% | 201,905 | -44.5% | 2.05% | -7.5% |
| Q2 2021 | $35,309,000 | +37.5% | 363,708 | -3.2% | 2.22% | +23.7% |
| Q1 2021 | $25,676,000 | +10.8% | 375,654 | +38.9% | 1.79% | 0.0% |
| Q4 2020 | $23,173,000 | +41.5% | 270,362 | +7.3% | 1.79% | +1.1% |
| Q3 2020 | $16,379,000 | +280.0% | 251,946 | +327.3% | 1.77% | +102.4% |
| Q2 2020 | $4,310,000 | -21.1% | 58,958 | -63.3% | 0.88% | -17.8% |
| Q1 2020 | $5,462,000 | -30.2% | 160,511 | +11.7% | 1.06% | +32.0% |
| Q4 2019 | $7,824,000 | +14.4% | 143,717 | -12.3% | 0.81% | +40.2% |
| Q3 2019 | $6,839,000 | -3.9% | 163,919 | +0.8% | 0.58% | -11.9% |
| Q2 2019 | $7,118,000 | +28.0% | 162,558 | +50.5% | 0.65% | +31.7% |
| Q1 2019 | $5,561,000 | +45.2% | 108,042 | +4.3% | 0.50% | +20.4% |
| Q4 2018 | $3,831,000 | +17.3% | 103,610 | +19.1% | 0.41% | +57.3% |
| Q3 2018 | $3,267,000 | -5.6% | 87,014 | -0.6% | 0.26% | +7.8% |
| Q2 2018 | $3,460,000 | +52.2% | 87,546 | -0.8% | 0.24% | +49.1% |
| Q1 2018 | $2,273,000 | -36.9% | 88,239 | -8.4% | 0.16% | -34.5% |
| Q3 2017 | $3,602,000 | +49.7% | 96,367 | +0.2% | 0.25% | +46.5% |
| Q2 2017 | $2,406,000 | – | 96,218 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |